OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Global Antimicrobial Resistance is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
2019 novel coronavirus (2019-nCoV) outbreak: A new challenge	215
Environmental antimicrobial resistance and its drivers: a potential threat to public health	152
Resistance to ceftazidime–avibactam and underlying mechanisms	136
A global perspective on the convergence of hypervirulence and carbapenem resistance in Klebsiella pneumoniae	114
Implementation of antimicrobial stewardship programmes in African countries: a systematic literature review	98
Phage therapy for treatment of virulent Klebsiella pneumoniae infection in a mouse model	91
Virulence evolution, molecular mechanisms of resistance and prevalence of ST11 carbapenem-resistant Klebsiella pneumoniae in China: A review over the last 10 years	76
Vitamin D deficiency and the COVID-19 pandemic	75
Reduced susceptibility mechanism to cefiderocol, a siderophore cephalosporin, among clinical isolates from a global surveillance programme (SIDERO-WT-2014)	69
Antibiotic resistance surveillance systems: A review	69
Antimicrobial activity of LysSS, a novel phage endolysin, against Acinetobacter baumannii and Pseudomonas aeruginosa	65
Resistance to ceftazidime/avibactam in infections and colonisations by KPC-producing Enterobacterales: a systematic review of observational clinical studies	62
Possible application of high-dose vitamin C in the prevention and therapy of coronavirus infection	61
Comparative efficacy and safety of combination therapy with high-dose sulbactam or colistin with additional antibacterial agents for multiple drug-resistant and extensively drug-resistant Acinetobacte	59
Incidence of bacterial and fungal bloodstream infections in COVID-19 patients in intensive care: An alarming “collateral effect”	59
Challenges in the management of chronic wound infections	58
Exploring the future of infectious disease treatment in a post-antibiotic era: A comparative review of alternative therapeutics	53
Non-antibiotic antimicrobial agents to combat biofilm-forming bacteria	53
Procalcitonin as an antibiotic stewardship tool in COVID-19 patients in the intensive care unit	52
The lurking scourge of multidrug resistant Candida auris in times of COVID-19 pandemic	52
Antimicrobial resistance of Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis and Tannerella forsythia in periodontitis patients	51
Italian young doctors’ knowledge, attitudes and practices on antibiotic use and resistance: A national cross-sectional survey	51
Presence of heavy metal resistance genes in Escherichia coli and Salmonella isolates and analysis of resistance gene structure in E. coli E308	46
Bedaquiline: Current status and future perspectives	43
A descriptive case series of pharmacokinetic/pharmacodynamic target attainment and microbiological outcome in critically ill patients with documented severe extensively drug-resistant Acinetobacter ba	43

Emergence of Escherichia coli harbouring mcr-1 and mcr-3 genes in North West Algerian farmlands	42
Carbapenemase-producing Gram-negative bacteria in aquatic environments: a review	40
Carbapenem-resistant Klebsiella pneumoniae in ICU-admitted COVID-19 patients: Keep an eye on the ball	40
Cefiderocol for compassionate use in the treatment of complicated infections caused by extensively and pan-resistant Acinetobacter baumannii	39
Relationship between virulence factors and antimicrobial resistance in Staphylococcus aureus from bovine mastitis	38
Minocycline, focus on mechanisms of resistance, antibacterial activity, and clinical effectiveness: Back to the future	37
Genomic characteristics of clinically important ST11 Klebsiella pneumoniae strains worldwide	36
In vitro activity of imipenem/relebactam against Enterobacteriaceae and Pseudomonas aeruginosa isolated from intraabdominal and urinary tract infection samples: SMART Surveillance United States 2015–2	35
Diversity analysis and metagenomic insights into antibiotic and metal resistance among Himalayan hot spring bacteriobiome insinuating inherent environmental baseline levels of antibiotic and metal tol	35
Risk factors for carbapenem-resistant Klebsiella pneumoniae infection: A meta-analysis	34
Revealing antibiotic resistance in therapeutic and dietary probiotic supplements	34